Value proposition

Expertise that matters

Mercodia utilizes its 30+ years of experience as a world-leading manufacturer of cardiometabolic immunoassays to provide tailored bioanalysis solutions for pharma and biotech companies.

We specialize in assay development and validation, PK/PD, immunogenicity testing, and biomarker testing, mainly focusing on large molecules, peptides, and oligonucleotide therapeutics in preclinical and clinical development. We are GLP-certified and work in accordance with ICH GCP, EMA, and FDA guidelines.

Our team of expert scientists quickly provides reproducible, reliable, and high-quality data that meets regulatory requirements. We prioritize speed and flexibility while delivering cost-effective solutions.

Our vision is to improve human health by offering our products and services to scientists around the globe. We serve our customers from our manufacturing and service lab facilities in Uppsala, Sweden, and Winston-Salem, USA, and are a trusted partner to some of the most renowned universities, pharmaceutical, and biotech companies around the world.

Development and manufacturing of ELISA assays for clinical and research applications within diabetes, metabolic disease, bioanalysis, bioanalytical services, NAFLD/NASH, ELISA, immunoassays, Glucagon, Insulin, NAFLD, NASH, GIP, GLP-1, Diabetes, Obesity, Cardiovascular disease, and Oxidized LDL